BACKGROUND This study aimed to monitor the prevalence of HIV-1 drug resistance and risk factors associated with drug resistance in ART-failure individuals in Liaoning Province, China. PATIENTS AND METHODS Plasma… Click to show full abstract
BACKGROUND This study aimed to monitor the prevalence of HIV-1 drug resistance and risk factors associated with drug resistance in ART-failure individuals in Liaoning Province, China. PATIENTS AND METHODS Plasma samples were collected from HIV-1-positive individuals who experienced ART failure in Liaoning Province between April 2018 and September 2019.Genotype resistance test was performed using an in-house assay on these collected samples. Factors associated with drug resistance were identified by logistic regression analysis. RESULTS We collected a total of 468 ART-failure individuals, of which 256 were successfully included in the final study. Of these, the most predominant genotype was CRF01_AE, accounting for 77.73%. The resistance rate to any of the three classes of antiretroviral drugs (NNRTIs, NRTIs, and PIs) was 64.84%. Among 256 ART-failure patients, 62.89% showed drug resistance to NNRTIs, 50.39% to NRTIs, and 3.13% to PIs. G190S (31.25%) and Y181C (25.78%) mutations were the most common NNRTIs resistance mutations. K65R (29.69%), M184V (28.52%) were the most common NRTIs resistance mutations. Factors associated with drug resistance included current ART regimen and viral load. CONCLUSION The high drug resistance rate among ART-failure individuals in Liaoning Province needs more attention. Corresponding strategies for the risk factors associated with HIV drug resistance can better control and prevent the prevalence of resistance.
               
Click one of the above tabs to view related content.